Evidence map›Paper›PMID 36875887›Full record

ArticleFrontiers in toxicology2023

Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke.

Fiona Chapman, Sarah Jean Pour, Roman Wieczorek, Edgar Trelles Sticken, Jessica Budde, Karin Röwer, Sandra Otte, Elizabeth Mason, Lukasz Czekala, Thomas Nahde and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in toxicology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. The respiratory health effects of heated tobacco product aerosols in a primary human airway epithelial cell model.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Fiona ChapmanImperial Brands PLC, Bristol, United Kingdom.
Sarah Jean PourReemtsma Cigarettenfabriken GmbH, Hamburg, Germany.
Roman WieczorekReemtsma Cigarettenfabriken GmbH, Hamburg, Germany.
Edgar Trelles StickenReemtsma Cigarettenfabriken GmbH, Hamburg, Germany.
Jessica BuddeReemtsma Cigarettenfabriken GmbH, Hamburg, Germany.
Karin RöwerReemtsma Cigarettenfabriken GmbH, Hamburg, Germany.
Sandra OtteReemtsma Cigarettenfabriken GmbH, Hamburg, Germany.
Elizabeth MasonImperial Brands PLC, Bristol, United Kingdom.
Lukasz CzekalaImperial Brands PLC, Bristol, United Kingdom.
Thomas NahdeReemtsma Cigarettenfabriken GmbH, Hamburg, Germany.
Grant O'ConnellImperial Brands PLC, Bristol, United Kingdom.
Liam SimmsImperial Brands PLC, Bristol, United Kingdom.
Matthew StevensonImperial Brands PLC, Bristol, United Kingdom.
Imperial Brands (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tobacco harm reduction (THR) involves providing adult smokers with potentially reduced harm modes of nicotine delivery as alternatives to smoking combustible cigarettes. Heated tobacco products (HTPs) form a category with THR potential due to their ability to deliver nicotine and flavours through heating, not burning, tobacco. By eliminating burning, heated tobacco does not produce smoke but an aerosol which contains fewer and lower levels of harmful chemicals compared to cigarette smoke. In this study we assessed the

Indexed as

cigaretteheated tobaccoin vitroMucilAir™repeat exposuretobacco harm reduction

Identifiers

PMID36875887
PMCPMC9979258
OpenAlexW4321085529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.